PROTAC for targeted degradation of tyrosinase, and application thereof
A compound and structural formula technology, applied in the field of compounds targeting the degradation of tyrosinase, can solve problems such as skin damage and adverse off-target effects
Active Publication Date: 2021-12-03
CHENGDU INST OF BIOLOGY CHINESE ACAD OF S
View PDF7 Cites 3 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
In addition, in order to produce inhibition, tyrosinase inhibitors need to continuously occupy the active site of the target protein, but high doses can cause undesirable off-target effects and cause damage to the skin
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 2
[0035] Design and synthetic route of targeting small molecules with levodopa or 3,4-dihydroxyphenylpropionic acid
[0036]
Embodiment 3
[0038] Synthetic route of alkane carbon chain compounds (L-C2—L-C10) targeting the degradation of tyrosinase
[0039]
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More
Abstract
The invention relates to tyrosinase-targeted PROTAC and application thereof, and belongs to the technical field of skin whitening cosmetic new raw materials and skin disease treatment drugs. The technical problem to be solved by the invention is to provide the compound for targeted degradation of tyrosinase by using PROTAC, and a salt, a prodrug, a hydrate or a solvate thereof. The structural formula of the PROTAC molecule is shown as a formula I in the specification. A series of tyrosinase-targeted PROTAC molecules are successfully prepared by coupling tyrosinase ligands with ligands of E3 ligase through linkers of different types and different chain lengths, can effectively target a target protein and reduce the content of tyrosinase in cells, have a better effect of reducing melanin in vivo and in vitro, are lower in toxicity to normal cells, and meet the characteristics of high efficiency and low toxicity.
Description
technical field [0001] The invention relates to a compound, a technical method and an application for targeting and degrading tyrosinase (tyrosinase, TYR for short). Background technique [0002] Hyperpigmentation is the process by which melanocytes in the skin and hair follicles synthesize melanin, which protects the epidermis from UV radiation, environmental pollutants, and toxic drugs and chemicals. However, abnormal levels of melanin can lead to serious skin conditions including freckles, melasma, senile lentils and pigmented acne scars. In addition, epidermal skin pigmentation increases markedly with skin wound healing and UV exposure. Therefore, regulation of melanin production is an important avenue for the treatment of medical pigmentation disorders and safe cosmetic practice. In fact, the synthesis of melanin is determined by the main rate-limiting enzyme, tyrosinase (EC1.14.18.1, TYR for short), which catalyzes the hydroxylation of tyrosine to 3,4-dihydroxyphenyl...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D401/04A61P17/00A61K31/454A61K8/49A61Q19/02A61Q19/00
CPCC07D401/04A61P17/00A61K8/4926A61Q19/02A61Q19/00
Inventor 唐卓付丁强袁奕李光勋
Owner CHENGDU INST OF BIOLOGY CHINESE ACAD OF S
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com